Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients

Molecular Psychiatry volume 12, pages 794–795 (2007)Cite this article

Tardive dyskinesia (TD) is a potentially irreversible movement disorder related to chronic antipsychotic medication exposure. The etiology is unknown, though genetic factors are likely contributors.1 Although the dopamine D2 receptor has been recognized as the main target for antipsychotics, studies investigating potential involvement of D2 gene (DRD2) polymorphisms in TD have yielded mixed results.2 Of these polymorphisms, TaqIA and −141C Ins/Del, have been studied most extensively.

The −141C Del allele has been reported to decrease DRD2 promoter activity in vitro, while two in vivo studies showed the Del allele to be associated either with an increase in striatal D2 binding or with no significant difference.2 The Taq1A polymorphism was recently discovered to reside in the coding region of an overlapping gene coding for a serine/threonine kinase, and cause an amino-acid change.2 However, the A1 (T) allele has been associated with reduced D2 levels in most reported studies.2

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Müller DJ, Schulze TG, Knapp M, Held T, Krauss H, Weber T et al. Acta Psychiatrica Scand 2001; 104: 375–379.

    Article  Google Scholar 

  2. Zai CC, Hwang RW, DeLuca V, Muller DJ, King N, Zai GC et al. Int J Neuropsychopharmacol 2006; Sep 7: 1–13.

    Google Scholar 

  3. Chen CH, Wei FC, Koong FJ, Hsiao KJ . Biol Psychiatry 1997; 41: 827–829.

    Article  CAS  Google Scholar 

  4. Inada T, Arinami T, Yagi G . Int J Neuropsychopharmacol 1999; 2: 181–186.

    Article  CAS  Google Scholar 

  5. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J . Am J Med Genet 2001; 105B: 774–778.

    Article  Google Scholar 

  6. Chong SA, Tan EC, Tan CH, Mythily CH, Chan YH . Am J Med Genet 2003; 116B: 51–54.

    Article  Google Scholar 

  7. Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M et al. Pharmacogenomics J 2003; 3: 277–283.

    Article  CAS  Google Scholar 

  8. Liou Y-J, Lai I-C, Liao D-L, Chen J-Y, Bai Y-M, Chen T-T et al. Schizophr Res 2006; 86: 323–325.

    Article  Google Scholar 

  9. Bakker PR, van Harten PN, van Os J . Schizophr Res 2006; 83: 185–192.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, ON, Canada

    C C Zai, V De Luca, R W Hwang, A Voineskos, D J Müller, G Remington & J L Kennedy

  2. Department of Psychiatry, Institute of Medical Science, University of Toronto, Toronto, ON, Canada

    C C Zai, V De Luca, R W Hwang, A Voineskos & J L Kennedy

  3. Department of Psychiatry, Charité University Medicine Berlin, Charité Campus Mitte, Berlin, Germany

    D J Müller

Authors
  1. C C Zai
    View author publications

    Search author on:PubMed Google Scholar

  2. V De Luca
    View author publications

    Search author on:PubMed Google Scholar

  3. R W Hwang
    View author publications

    Search author on:PubMed Google Scholar

  4. A Voineskos
    View author publications

    Search author on:PubMed Google Scholar

  5. D J Müller
    View author publications

    Search author on:PubMed Google Scholar

  6. G Remington
    View author publications

    Search author on:PubMed Google Scholar

  7. J L Kennedy
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to J L Kennedy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zai, C., De Luca, V., Hwang, R. et al. Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients. Mol Psychiatry 12, 794–795 (2007). https://doi.org/10.1038/sj.mp.4002023

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.mp.4002023

This article is cited by

Search

Advanced search

Quick links